semaglutide vs empagliflozin Glycaemic efficacy of oral versus empagliflozin. Results SGLT2 vs GLP-1 for CKD:

Yeah, I was out in the hills

Although the insulinotropic effect of GIP is diminished in patients with type 2 diabetes, studies have found that GIP receptor agonists can induce a degree of weight loss and, when used in combination with GLP-1, can produce synergistic effects, enhancing blood glucose reduction and weight loss

minor timing adjustments should be coordinated, not routine

Four randomized controlled trials tested ALC in patients with neuropathy secondary to diabetes and to antiretroviral therapy for HIV

Somatostatin analog SMS 201995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy